MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR 3.540
0.00 (0.00%)
May 8, 2026, 5:35 PM CET
ETR:MED Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 794.49 | 784.49 | 748.75 | 730.07 | 704.7 | 673.14 |
Other Revenue | 15.99 | 16.63 | 13.12 | 31.58 | 13.89 | 10.65 |
| 810.48 | 801.12 | 761.88 | 761.65 | 718.58 | 683.79 | |
Revenue Growth (YoY) | 6.77% | 5.15% | 0.03% | 5.99% | 5.09% | 3.32% |
Cost of Revenue | 638.85 | 632.86 | 615.49 | 599.38 | 587.75 | 561.6 |
Gross Profit | 171.63 | 168.26 | 146.39 | 162.26 | 130.84 | 122.19 |
Selling, General & Admin | 5.1 | 5.1 | 4.9 | 4.3 | 5.6 | 3.5 |
Other Operating Expenses | 49.87 | 50.67 | 40.72 | 63.93 | 36.9 | 35.62 |
Operating Expenses | 107.38 | 108.08 | 95.9 | 120.51 | 120.5 | 119.36 |
Operating Income | 64.25 | 60.18 | 50.49 | 41.75 | 10.34 | 2.83 |
Interest Expense | -20.09 | -20.8 | -22.7 | -22.5 | -10.08 | -9.06 |
Interest & Investment Income | 1.78 | 1.78 | 2.62 | 2.54 | 0.88 | 0.05 |
Earnings From Equity Investments | 0.12 | 0.12 | - | - | - | 0.16 |
Other Non Operating Income (Expenses) | 1.77 | 1.84 | 1.71 | 3.25 | 1.8 | 1.8 |
EBT Excluding Unusual Items | 47.84 | 43.12 | 32.12 | 25.04 | 2.94 | -4.22 |
Impairment of Goodwill | -7.56 | -7.56 | - | -33.13 | - | -0.02 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.24 | 0.09 |
Asset Writedown | -0.36 | -0.36 | - | -0.6 | - | - |
Other Unusual Items | - | - | - | - | 6.6 | 6.6 |
Pretax Income | 39.92 | 35.2 | 32.12 | -8.69 | 9.78 | 2.45 |
Income Tax Expense | 10.38 | 9.3 | 7.21 | 2.04 | 0.06 | 0.96 |
Earnings From Continuing Operations | 29.54 | 25.9 | 24.91 | -10.72 | 9.72 | 1.49 |
Minority Interest in Earnings | -0.36 | -0.42 | -0.07 | -0.05 | -0.28 | -0.02 |
Net Income | 29.18 | 25.49 | 24.84 | -10.78 | 9.44 | 1.46 |
Net Income to Common | 29.18 | 25.49 | 24.84 | -10.78 | 9.44 | 1.46 |
Net Income Growth | 11.90% | 2.60% | - | - | 545.98% | - |
Shares Outstanding (Basic) | 50 | 48 | 48 | 48 | 48 | 48 |
Shares Outstanding (Diluted) | 50 | 48 | 48 | 48 | 48 | 48 |
EPS (Basic) | 0.58 | 0.54 | 0.52 | -0.23 | 0.20 | 0.03 |
EPS (Diluted) | 0.58 | 0.54 | 0.52 | -0.23 | 0.20 | 0.03 |
EPS Growth | 5.90% | 3.18% | - | - | 562.50% | - |
Free Cash Flow | 50.93 | 54.01 | 42.52 | 43.58 | 10.27 | 66.74 |
Free Cash Flow Per Share | 1.01 | 1.14 | 0.90 | 0.92 | 0.22 | 1.41 |
Dividend Per Share | 0.040 | 0.040 | 0.040 | - | - | - |
Gross Margin | 21.18% | 21.00% | 19.21% | 21.30% | 18.21% | 17.87% |
Operating Margin | 7.93% | 7.51% | 6.63% | 5.48% | 1.44% | 0.41% |
Profit Margin | 3.60% | 3.18% | 3.26% | -1.42% | 1.31% | 0.21% |
Free Cash Flow Margin | 6.28% | 6.74% | 5.58% | 5.72% | 1.43% | 9.76% |
EBITDA | 86.69 | 82.52 | 71.91 | 66.65 | 36.93 | 29.24 |
EBITDA Margin | 10.70% | 10.30% | 9.44% | 8.75% | 5.14% | 4.28% |
D&A For EBITDA | 22.44 | 22.34 | 21.43 | 24.9 | 26.59 | 26.41 |
EBIT | 64.25 | 60.18 | 50.49 | 41.75 | 10.34 | 2.83 |
EBIT Margin | 7.93% | 7.51% | 6.63% | 5.48% | 1.44% | 0.41% |
Effective Tax Rate | 25.99% | 26.41% | 22.44% | - | 0.59% | 39.28% |
Revenue as Reported | 813.68 | 804.32 | 765.08 | 766.75 | 722.32 | 687.08 |
Advertising Expenses | - | - | - | - | 2.2 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.